6 unchanged sentences
The description is included per Regulation S-K, Item 103(c) of the Securities Exchange Act of 1934.
−Removed: EIDP Divested Neoprene Facility, La Place, Louisiana - EPA Compliance Inspection
−Removed: In 2016, the EPA conducted a focused compliance investigation at the Denka Performance Elastomer LLC (“Denka”) neoprene manufacturing facility in La Place, Louisiana.
−Removed: EIDP sold the neoprene business, including this manufacturing facility, to Denka in the fourth quarter of 2015.
−Removed: Subsequent to this inspection, the U.S.
−Removed: Environmental Protection Agency (“EPA”), the U.S.
−Removed: Department of Justice (“DOJ”), the Louisiana Department of Environmental Quality (“Louisiana DEQ”), EIDP and Denka began discussions in the spring of 2017 relating to the inspection conclusions and allegations of noncompliance arising under the Clean Air Act, including leak detection and repair.
−Removed: For many years, Denka, EIDP, and DuPont, as the current landlord, continued to work with the EPA, DOJ and Louisiana DEQ to achieve an amicable resolution.
−Removed: On February 28, 2023, the United States Government, on behalf of the EPA, filed a lawsuit against Denka in Federal Court in Louisiana claiming that Denka’s continued chloroprene emissions constitute an imminent damage to the public.
−Removed: A DuPont subsidiary is identified as a defendant in this matter simply as a landlord/property owner.
−Removed: The lawsuit seeks injunctive relief requiring Denka to eliminate the alleged imminent and substantial endangerment posed by its chloroprene emissions from the facility.
−Removed: In January 2025, the Court set a pre-trial schedule with an anticipated 10-day trial to begin in the second quarter 2025.
New Jersey Directive PFAS
−Removed: On March 25, 2019, the New Jersey Department of Environmental Protection (“NJDEP”) issued a Directive and Notice to Insurers to a number of companies, including Chemours, DowDuPont, EIDP, and certain DuPont subsidiaries.
−Removed: NJDEP’s allegations relate to former operations of EIDP involving poly- and perfluoroalkyl substances, (“PFAS”), including PFOA and PFOA- replacement products.
−Removed: The NJDEP seeks past and future costs of investigating, monitoring, testing, treating, and remediating New Jersey’s drinking water and waste systems, private drinking water wells and natural resources including groundwater, surface water, soil, sediments and biota.
−Removed: The Directive seeks certain information as to future costs and information related to the historical uses of PFAS and replacement chemicals including “information ranging from use and discharge of the chemicals through wastewater treatment plants, air emissions, and sales of products containing the chemicals to current development, manufacture, use and release of newer chemicals in the state.”
+Added: This matter is resolved by the proposed Judicial Consent Order with the State of New Jersey reached in August 2025.
+Added: See Note 16 to the Consolidated Financial Statements for more information.
+Added: Spruance Site, Richmond, Virginia-EPA Notice to Show Cause
+Added: On March 25, 2025, Region 3 of EPA issued a Notice to Show Cause letter to the Company's Spruance facility in Richmond, Virginia.
+Added: The letter alleges violations of the Resource Conservation and Recovery Act ("RCRA") relating to the storage of hazardous waste at the site as well as alleged discharges of hazardous waste to the subsurface groundwater from an on-site impoundment.
+Added: The Company is engaged in discussions with the EPA regarding this matter.
MINE SAFETY DISCLOSURES
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.